Author/Authors :
Jean-Pierre Zarski، نويسنده , , Patrick Marcellin، نويسنده , , Vincent Leroy، نويسنده , , Christian Trepo، نويسنده , , Didier Samuel، نويسنده , , Nathalie Ganne-Carrié، نويسنده , , Karl Barange، نويسنده , , Valérie Canva، نويسنده , , Michel Doffoel، نويسنده , , Paul Cales and the Fédération nationale des Pôles de référence et des Réseaux Hépatites، نويسنده ,
Abstract :
Background/Aims
An increasing prevalence of HBe antigen (HBeAg) negative chronic hepatitis B has been recently reported in many countries. The aim of this study was to analyze the frequency and the characteristics of HBeAg-negative as compared with HBeAg-positive chronic hepatitis B in France.
Methods
Eight hundred and sixty-five patients with histologically proven chronic hepatitis B seen in 26 University centers were included. The proportion with HBeAg-negative chronic hepatitis B was 72% and higher in patients born in Africa, Middle East, Eastern, and Southern Europe than in those of French or Asian origin. HBeAg-negative patients were significantly older (p < 0.001) and had lower ALT levels and HBV DNA serum levels (p < 0.01) than HBeAg-positive patients. An unknown source of infection was more prevalent in HBeAg-negative patients (p < 0.05). Fibrosis score (p < 0.05) and proportion of cirrhosis (p < 0.01) were significantly higher in HBeAg-negative patients. Age older than 50 years, male gender and viral load lower than 5 logs10 copies/mL were independently associated with cirrhosis.
Results
HBeAg-negative chronic hepatitis B is predominant in France. This observation is important for an optimized clinical management and future therapeutic trials in chronic hepatitis B.